^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners
    DRUG:

    ART6043

    i
    Other names: ART6043, ART-6043, ART 6043
    Associations

    News

    Trials
    Company:
    Artios Pharma
    Drug class:
    POLQ inhibitor
    Related drugs:
    Associations

    News

    Trials
    over1year
    Study of ART6043 in Advanced/Metastatic Solid Tumors Patients (clinicaltrials.gov)
    P1/2, N=250, Recruiting, Artios Pharma Ltd | Not yet recruiting --> Recruiting
    Enrollment open • Metastases
    |
    HER-2 (Human epidermal growth factor receptor 2)
    |
    Lynparza (olaparib) • Talzenna (talazoparib) • ART6043
    over1year
    Study of ART6043 in Advanced/Metastatic Solid Tumors Patients (clinicaltrials.gov)
    P1/2, N=250, Not yet recruiting, Artios Pharma Ltd
    New P1/2 trial • Metastases
    |
    HER-2 (Human epidermal growth factor receptor 2)
    |
    Lynparza (olaparib) • Talzenna (talazoparib) • ART6043